AI & Automation in Compliance
Artificial intelligence and automation are entering regulated workflows faster than the guidance can keep up. This pillar covers a practical framework for validating AI-enabled GxP systems and building automation tools that stay inside the lines.
19 articlesInspection Readiness for AI-Enabled GxP Systems
What inspectors look for when an AI or machine learning model sits inside a regulated process, and how to assemble the inventory, validation, data-lineage, change, oversight, and vendor evidence that survives the questions.
AI Model Credibility and Trust: Earning the Right to Rely on a Model
What model credibility actually means in a regulated setting, how to size the evidence to the risk using context of use, model influence, and decision consequence, and how to build trust in an AI output that holds up in an inspection.
AI in Regulatory Affairs and CMC: From Tools to Submission-Ready Governance
How AI is used across regulatory affairs and CMC writing, submission assembly, regulatory intelligence, and change management, and the governance that keeps AI-assisted content accurate, traceable, and ready to put in front of a health authority.
AI Risk Assessment for GxP Systems: Sizing the Effort to the Real Risk
How to run a risk assessment for AI and machine learning in regulated pharma, biotech, and medical device environments: classifying AI use patterns, scoring AI-specific failure modes like drift and confabulation, and producing an inspection-defensible rationale when the formal guidance is still forming.
Workforce and Organizational Readiness for AI in Quality
How to assess and build the people, skills, roles, operating model, and governance culture a regulated quality organization needs before it can use AI safely and defensibly.
Building AI Tools for GxP: What Actually Works
Practical lessons from building AI-assisted compliance tools in regulated environments, where the hype ends and the useful, validatable work begins.
Data Readiness for AI in Manufacturing and Quality Operations
How to get manufacturing and quality data fit for training and running AI models: data quality dimensions, labeling and ground truth, contextualization, ALCOA+ for training data, governance, lineage, train/validation/test splitting, leakage, and bias, with a worked readiness assessment.
The EU AI Act and Life Sciences: Scope, Risk Tiers, and GxP Overlap
A working account of the EU AI Act for biotech, pharma, biologics, and combination-product companies: scope, the risk-tier classification, how it overlaps with GxP and combination-product obligations, the phased dates, and provider versus deployer duties.
Using Generative AI in Deviation, CAPA, and Investigation Workflows
A practical look at putting generative AI to work drafting deviations, assisting root cause analysis, drafting CAPAs, and summarizing complaints and trends, with the guardrails, validation, and data-integrity controls that keep it inspection-defensible.
Validating RPA and Workflow Automation in Quality Operations
How to validate robotic process automation and workflow bots that touch GxP records, with a risk-based approach that fits modern CSA thinking rather than treating a bot like a monolithic application.
Validating Scripts, Notebooks, and Low-Code Analytics (Python, R, Power BI) in GxP
How to bring version control, peer review, environment control, and risk-based validation to Python scripts, R, Jupyter notebooks, and Power BI dashboards built on regulated GxP data.
AI Governance for GxP: Policy, Roles, and Lifecycle Oversight
How a regulated life-sciences organization governs AI across its lifecycle: the policy, the inventory, the roles, risk tiering, human oversight, change and retraining control, decommissioning, and the link back to quality risk management.
AI in Pharmacovigilance: Validating the Machines That Read Safety Data
How to deploy and validate AI and machine learning in drug safety, case intake, MedDRA coding, literature screening, and signal detection, with an inspection-defensible approach to a regulatory framework that is still forming.
AI/ML in Regulated Drug and Biologic Software: Change Control and Regulatory Expectations
How regulators frame AI and machine learning in software that supports drug, biologic, and combination products, covering the model lifecycle, good machine learning practice, the predetermined change control plan, transparency, and real-world performance monitoring, with a worked PCCP outline.
Validating AI-Based Automated Visual Inspection of Injectables
How to validate a machine-vision or deep-learning automated visual inspection system for parenteral products: the visual-inspection regulatory base, why AI changes the validation, how to qualify the camera-to-classifier chain, set defect-detection acceptance criteria, manage drift and model change, and defend it in an inspection.
Managing the GxP Machine Learning Lifecycle: Drift, Retraining, and Continuous Monitoring
How to run a machine learning model under GxP after go-live: detecting drift, deciding between locked and continuously learning models, and controlling retraining through change control and ongoing performance monitoring.
Qualifying Large Language Models and Generative AI for Regulated Use
A practical method for qualifying and evaluating LLMs and generative AI in GxP: setting acceptance criteria for a probabilistic system, designing golden datasets, measuring groundedness and hallucination, building guardrails, and monitoring in production.
Scaling AI from Pilot to Validated Production
How to move an AI use case from a promising pilot to a validated, monitored production system in a GxP environment: the pilot-to-production gap, MLOps under quality controls, validation at scale, drift monitoring, model change control, the data and infrastructure underneath, and a stage-gate operating model.
Validating AI-Enabled GxP Systems: A Framework Still Being Built
How to validate AI and machine learning systems in regulated pharma, biotech, biologics, and cell and gene therapy environments: what is genuinely different, where the regulatory framework has gaps, and a practical, inspection-defensible approach you can run today.